Colin Glenn Begley, Chief Scientific Officer & SVP at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 1,500 shares at $4.84 ($7K) on 2014-11-25, disclosed to the SEC on 2014-11-28.
Open-market purchase of $7k TLOG by Chief Scientific Officer & SVP. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.84 | 100 | $484 | 6.6% |
| 2 | $4.84 | 200 | $968 | 13.3% |
| 3 | $4.85 | 500 | $2K | 33.3% |
| 4 | $4.87 | 700 | $3K | 46.8% |
| Total | $4.86 avg | 1,500 | $7K | 100% |
| Filing → |
| TLOG | BUY | 2014-12-01 | $15K | — | Filing → |